This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1988-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Amagasaki, JP (1988)
- Kyoto, JP (2006)
Company Filing History:
Years Active: 1988-2006
Title: Jiro Fujisaki: Innovator in Liposome Preparations
Introduction
Jiro Fujisaki is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of liposome technologies. With a total of 2 patents, his work focuses on innovative solutions for urgent medical conditions.
Latest Patents
Fujisaki's latest patents include a liposome preparation that features a pipecolic acid derivative. This preparation is designed to provide rapid action in emergency situations, such as cerebral infarction. The invention emphasizes the use of lecithin as the primary liposome-forming lipid, while notably excluding cholesterol as a stabilizer. Another significant patent involves drug-containing lipid vesicle preparations, which are created by mixing an aqueous solution with phospholipids and lipophilic surfactants. This method results in the formation of lipid vesicles that can be dispersed in a medium to create an emulsion.
Career Highlights
Jiro Fujisaki is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in drug delivery systems, enhancing the efficacy of treatments.
Collaborations
Fujisaki has collaborated with notable colleagues, including Hiromitsu Yoshida and Seiji Sawai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Jiro Fujisaki's contributions to liposome preparations highlight his role as an innovator in the pharmaceutical industry. His patents reflect a commitment to developing effective solutions for critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
